Cyr61: a potential therapeutic target for prostate cancer.
Chang-Ming
CM
Lin
Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Chao-Zhao
CZ
Liang
D014408:Biomarkers, Tumor / Q000378:metabolism*; D055515:Cysteine-Rich Protein 61 / Q000378:metabolism*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis*
D014408:Biomarkers, Tumor; D055515:Cysteine-Rich Protein 61